Hailey 1.5/30 Tablet
Product Images NDC 68462-504

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Hailey 1.5/30 (NDC 68462-504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister

Blister
Blister packaging label for Hailey 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol) tablets USP, oral contraceptive tablets containing 1.5 mg norethindrone acetate and 30 mcg ethinyl estradiol. The package contains 21 tablets arranged in three rows labeled by week and day of the week. The front displays the product name, active ingredients, strength, and a warning to keep the package out of reach of children. Labeler is Glenmark Pharmaceuticals Inc., USA.*
FDA Label Image

Blister1

Blister1
An instructional diagram for Hailey 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) 1.5 mg/30 mcg. It shows a 21-tablet blister pack arranged in three rows labeled Week 1, Week 2, and Week 3, with circles corresponding to days of the week Sunday to Saturday. Arrows and text guide the user to start on Sunday for 'Sunday starters' or to place the day label strip for 'Day-1 starters.' The direction of pill intake is indicated from left to right for each week. A warning notes the package is not child resistant and to keep out of reach of children.*
FDA Label Image

Blister2

Blister2
An instructional diagram for Hailey 1.5/30 oral tablets (Norethindrone Acetate and Ethinyl Estradiol, 1.5 mg/30 mcg) showing a 3-week pill pack layout with 21 tablet positions arranged by day of the week. It includes directions for Sunday starters and Day-1 starters, with arrows indicating the sequence of tablet intake from left to right each week.*
FDA Label Image

Carton

Carton
Box label for Hailey 1.5/30 tablets by Glenmark Pharmaceuticals Inc. The oral tablet contains Norethindrone Acetate 1.5 mg and Ethinyl Estradiol 30 mcg. The carton holds 3 pouches, each with a blister card of 21 green tablets. The label includes storage instructions, usage directions for 21 days, and a barcode.*
FDA Label Image

Eestructure

Eestructure
Chemical structure diagram depicting the molecular formula of Ethinyl Estradiol, an active ingredient in Hailey 1.5/30 tablets.*
FDA Label Image

Structure2 (Image 01)

Structure2 (Image 01)
A forest plot displaying effect estimates and confidence intervals comparing Ever COC (Combined Oral Contraceptive) use versus Never COC use, and Current COC use versus Never Use. Studies are listed by name and year, showing odds ratios (OR), relative risks (RR), or hazard ratios (HR) with corresponding confidence intervals on a horizontal scale ranging approximately from -1.50 to 2.00.*
FDA Label Image
FDA Label Image

Logo1

FDA Label Image

Norethindrone

Norethindrone
Chemical structure diagram of the active ingredient in Hailey 1.5/30, which includes Norethindrone Acetate and Ethinyl Estradiol. The structure shows the steroid backbone with specific functional groups including acetyl and ethynyl moieties.*
FDA Label Image

Pouch

Pouch
Label for Hailey 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol) tablets USP, 1.5 mg/30 mcg, oral tablet. The label indicates a blister card of 21 green tablets, with each tablet containing 1.5 mg norethindrone acetate and 30 mcg ethinyl estradiol. Manufactured by Glenmark Pharmaceuticals Inc., USA. The label includes storage instructions, dosage reminder, bar code, and branding with Glenmark logo.*
FDA Label Image

Table2

Table2
A bar chart showing circulatory disease mortality rates per 100,000 women by age groups (15–24, 25–34, 35–44, 45+) and smoking status, comparing oral contraceptive ever-users and controls. Mortality rates increase with age, with smokers who are ever-users of oral contraceptives showing the highest rates, particularly in the 45+ group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.